Dr. Zheyuan LuoScientific Leader at GlaxoSmithKlineSpeaker
Profile
Dr. Zheyuan Luo is a Scientific Leader in Biopharm Drug Substance Development at GlaxoSmithKline, specializing in downstream process development for a range of biotherapeutics. Prior to transitioning to process development in 2018, she spent 15 years in analytical development, gaining extensive experience in separation sciences, structure-function relationships, and regulatory filings.
Agenda Sessions
Mitigation of Particulate Formation in Downstream Purification for an Intensified Monoclonal Antibody Process
, 11:40amView Session